There are a broad range of investment vehicles available to life sciences innovators, to move their work from concept to the market. This presentation will...
Join CohnReznick’s National Tax Team along with members of our SBA Task Force as we dive into the new relief measures and the impact on...
The National Institute on Aging (NIA) Office of Small Business Research (OSBR) is offering you an opportuntity to learn more about NIA's Small Business Innovation...
As plans for a broader vaccine rollout unfold, the questions and decisions facing employers have multiplied. Beyond the important question of whether employers can mandate...
If the current pandemic has taught us anything, it is the importance of monitoring not only our own health but the health of our loved...
The Paycheck Protection Program (PPP) has been a huge success. For government contractors there are hidden – and expensive – pitfalls regarding loan forgiveness. CohnReznick...
Commercializing novel scientific products and technologies is complex—especially for startups. To support entrepreneurs along this journey, the National Institutes of Health (NIH) is offering a...
Overview: With investment levels in rare & ultra-rare diseases increasing, are they all attractive for biotechs & venture capital? What factors are executives & investors...
For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established...
The National Forum on COVID-19 Vaccine is a virtual event that will unite representatives from across the US government, with tribal, state, local, and territorial...